This volume is a very comprehensiv...

This volume is a very comprehensive treatise upon the biology of lung cancer. It consists of 12 sections, each authored at international experts in their fields. It has limited usefulness to the clinician, on the contrary sections of the book will probably be of interest to various subspecialists. The section upon pathobiology is very detailed, on the contrary practical only for the pathologist who has access to sophisticated laboratory techniques. Likewise, the section in succession biochemical markers deals with laboratory ordeals which are not easily available to principally clinical laboratories.

The section forward oncogenes in human lung cancer is to a high degree detailed. The accompanying glossary makes it a bit more palatable for the average reader. Perhaps it would have been better placed at the beginning rather than at the last of the section.

Sections 7 8 and 9 deal with antigens and, again, is of a great deal of more interest to the research-oriented physician than to the clinician. The last three sections deal with limited access therapy, specifically with monoclonal antibodies and remedy immunoconjugates. These are of interest to all those treating cancer however pertain primarily to the phase I and II research protocols.

The bibliography which come nexts each section is extensive. The combined bibliographies and indices constitutes 30 percent of the main division This book is body 37 of a series entitled Lung Biology in Health and Disease, which deals with various aspects of pulmonary physiology.

The price of $9950 would certainly be an inhibitory factor for a clinician further is probably reasonable for the serious investigator in the field as it does contain a wealth of information.

COPYRIGHT 1989 American body of Chest Physicians

COPYRIGHT 2004 Gale Group